Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Dermatomycoses Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Dermatomycoses Drugmarket, defines the market attractiveness level of Dermatomycoses Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Dermatomycoses Drug industry, describes the types of Dermatomycoses Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Dermatomycoses Drug market and the development prospects and opportunities of Dermatomycoses Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Dermatomycoses Drug market in Chapter 13.
By Player:
Sol-Gel Technologies Ltd
Helix BioMedix Inc
TGV-Laboratories
Blueberry Therapeutics Ltd
Dermala Inc
Biolab Farmaceutica Ltda
Viamet Pharmaceuticals Inc
Daewoong Pharmaceutical Co Ltd
Novan Inc
Anacor Pharmaceuticals Inc
Vyome Biosciences Pvt Ltd
By Type:
BB-2603
Clotrimazole
Dapaconazole
Others
By End-User:
Hospital
Clinic
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Dermatomycoses Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Dermatomycoses Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Dermatomycoses Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Dermatomycoses Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Dermatomycoses Drug Market Analysis and Outlook to 2022
-
7.1 Global Dermatomycoses Drug Consumption (2017-2022)
-
7.2 United States Dermatomycoses Drug Consumption (2017-2022)
-
7.3 Europe Dermatomycoses Drug Consumption (2017-2022)
-
7.4 China Dermatomycoses Drug Consumption (2017-2022)
-
7.5 Japan Dermatomycoses Drug Consumption (2017-2022)
-
7.6 India Dermatomycoses Drug Consumption (2017-2022)
-
7.7 South Korea Dermatomycoses Drug Consumption (2017-2022)
8 Region and Country-wise Dermatomycoses Drug Market Analysis and Outlook to 2028
-
8.1 Global Dermatomycoses Drug Consumption Forecast (2022-2028)
-
8.2 United States Dermatomycoses Drug Consumption Forecast (2022-2028)
-
8.3 Europe Dermatomycoses Drug Consumption Forecast (2022-2028)
-
8.4 China Dermatomycoses Drug Consumption Forecast (2022-2028)
-
8.5 Japan Dermatomycoses Drug Consumption Forecast (2022-2028)
-
8.6 India Dermatomycoses Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Dermatomycoses Drug Consumption Forecast (2022-2028)
9 Global Dermatomycoses Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Dermatomycoses Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global BB-2603 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Clotrimazole Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Dapaconazole Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Dermatomycoses Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Dermatomycoses Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Dermatomycoses Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global BB-2603 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Clotrimazole Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Dapaconazole Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Dermatomycoses Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Dermatomycoses Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Dermatomycoses Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Dermatomycoses Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Dermatomycoses Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Dermatomycoses Drug Market Competitive Analysis
-
14.1 Sol-Gel Technologies Ltd
-
14.1.1 Sol-Gel Technologies Ltd Company Details
-
14.1.2 Sol-Gel Technologies Ltd Dermatomycoses Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sol-Gel Technologies Ltd Dermatomycoses Drug Product and Service
-
14.2 Helix BioMedix Inc
-
14.2.1 Helix BioMedix Inc Company Details
-
14.2.2 Helix BioMedix Inc Dermatomycoses Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Helix BioMedix Inc Dermatomycoses Drug Product and Service
-
14.3 TGV-Laboratories
-
14.3.1 TGV-Laboratories Company Details
-
14.3.2 TGV-Laboratories Dermatomycoses Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 TGV-Laboratories Dermatomycoses Drug Product and Service
-
14.4 Blueberry Therapeutics Ltd
-
14.4.1 Blueberry Therapeutics Ltd Company Details
-
14.4.2 Blueberry Therapeutics Ltd Dermatomycoses Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Blueberry Therapeutics Ltd Dermatomycoses Drug Product and Service
-
14.5 Dermala Inc
-
14.5.1 Dermala Inc Company Details
-
14.5.2 Dermala Inc Dermatomycoses Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Dermala Inc Dermatomycoses Drug Product and Service
-
14.6 Biolab Farmaceutica Ltda
-
14.6.1 Biolab Farmaceutica Ltda Company Details
-
14.6.2 Biolab Farmaceutica Ltda Dermatomycoses Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Biolab Farmaceutica Ltda Dermatomycoses Drug Product and Service
-
14.7 Viamet Pharmaceuticals Inc
-
14.7.1 Viamet Pharmaceuticals Inc Company Details
-
14.7.2 Viamet Pharmaceuticals Inc Dermatomycoses Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Viamet Pharmaceuticals Inc Dermatomycoses Drug Product and Service
-
14.8 Daewoong Pharmaceutical Co Ltd
-
14.8.1 Daewoong Pharmaceutical Co Ltd Company Details
-
14.8.2 Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Product and Service
-
14.9 Novan Inc
-
14.9.1 Novan Inc Company Details
-
14.9.2 Novan Inc Dermatomycoses Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Novan Inc Dermatomycoses Drug Product and Service
-
14.10 Anacor Pharmaceuticals Inc
-
14.10.1 Anacor Pharmaceuticals Inc Company Details
-
14.10.2 Anacor Pharmaceuticals Inc Dermatomycoses Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Anacor Pharmaceuticals Inc Dermatomycoses Drug Product and Service
-
14.11 Vyome Biosciences Pvt Ltd
-
14.11.1 Vyome Biosciences Pvt Ltd Company Details
-
14.11.2 Vyome Biosciences Pvt Ltd Dermatomycoses Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Vyome Biosciences Pvt Ltd Dermatomycoses Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Dermatomycoses Drug
-
Figure Dermatomycoses Drug Picture
-
Table Global Dermatomycoses Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Dermatomycoses Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Dermatomycoses Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Dermatomycoses Drug Consumption by Country (2017-2022)
-
Figure United States Dermatomycoses Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Dermatomycoses Drug Consumption and Growth Rate (2017-2022)
-
Figure China Dermatomycoses Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Dermatomycoses Drug Consumption and Growth Rate (2017-2022)
-
Figure India Dermatomycoses Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Dermatomycoses Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Dermatomycoses Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Dermatomycoses Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Dermatomycoses Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Dermatomycoses Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Dermatomycoses Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Dermatomycoses Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Dermatomycoses Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global BB-2603 Consumption and Growth Rate (2017-2022)
-
Figure Global Clotrimazole Consumption and Growth Rate (2017-2022)
-
Figure Global Dapaconazole Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global BB-2603 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clotrimazole Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dapaconazole Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Dermatomycoses Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Dermatomycoses Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Sol-Gel Technologies Ltd (Foundation Year, Company Profile and etc.)
-
Table Sol-Gel Technologies Ltd Dermatomycoses Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sol-Gel Technologies Ltd Dermatomycoses Drug Product and Service
-
Table Helix BioMedix Inc (Foundation Year, Company Profile and etc.)
-
Table Helix BioMedix Inc Dermatomycoses Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Helix BioMedix Inc Dermatomycoses Drug Product and Service
-
Table TGV-Laboratories (Foundation Year, Company Profile and etc.)
-
Table TGV-Laboratories Dermatomycoses Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table TGV-Laboratories Dermatomycoses Drug Product and Service
-
Table Blueberry Therapeutics Ltd (Foundation Year, Company Profile and etc.)
-
Table Blueberry Therapeutics Ltd Dermatomycoses Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Blueberry Therapeutics Ltd Dermatomycoses Drug Product and Service
-
Table Dermala Inc (Foundation Year, Company Profile and etc.)
-
Table Dermala Inc Dermatomycoses Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dermala Inc Dermatomycoses Drug Product and Service
-
Table Biolab Farmaceutica Ltda (Foundation Year, Company Profile and etc.)
-
Table Biolab Farmaceutica Ltda Dermatomycoses Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biolab Farmaceutica Ltda Dermatomycoses Drug Product and Service
-
Table Viamet Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Viamet Pharmaceuticals Inc Dermatomycoses Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Viamet Pharmaceuticals Inc Dermatomycoses Drug Product and Service
-
Table Daewoong Pharmaceutical Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Product and Service
-
Table Novan Inc (Foundation Year, Company Profile and etc.)
-
Table Novan Inc Dermatomycoses Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novan Inc Dermatomycoses Drug Product and Service
-
Table Anacor Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Anacor Pharmaceuticals Inc Dermatomycoses Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Anacor Pharmaceuticals Inc Dermatomycoses Drug Product and Service
-
Table Vyome Biosciences Pvt Ltd (Foundation Year, Company Profile and etc.)
-
Table Vyome Biosciences Pvt Ltd Dermatomycoses Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vyome Biosciences Pvt Ltd Dermatomycoses Drug Product and Service
-
